R&D investment strategy
OZMOSI and Planview Just Solved Pharma’s Biggest Planning Problem
Pharmaceutical R&D has a data problem that has nothing to do with a shortage of data. Drug developers sit on enormous volumes of information: clinical trial registries, regulatory filings, scientific literature, competitor disclosures, pipeline announcements. The problem is that it lives in disconnected silos, built on inconsistent taxonomies, in formats that resist machine-readable analysis. A…
